Volume 32 Issue 6, June 2022

Radiotherapy (light provided by electricity infrastructure) combined with VEGF-C that augments MLVs (roads constructed by road construction team) together promotes antigen-presenting DC trafficking (locally grown fruits transported by truck), resulting in effective glioma treatment (poverty elimination). See pages 543-554 by Changping Zhou et al. for details.

Research Highlight

Amplifying natural antitumor immunity for personalized immunotherapy

Laura K. Donovan
Michael D. Taylor
Research Highlight 29 Mar 2022
Advertisement
PEN2: Metformin’s new partner at lysosome

Kei Sakamoto
Niels Jessen
Research Highlight 13 Apr 2022
Krebs and an alternative TCA cycle!

Mary T. Doan
Michael A. Teitell
Research Highlight 22 Apr 2022
Nuclear tetraspanin 8 promotes breast cancer progression

Kadellyn Sandoval
William A. Weiss
Research Highlight 13 Apr 2022

Top of page ⤴

Article

Derivation of totipotent-like stem cells with blastocyst-like structure forming potential

Yaxing Xu
Jingru Zhao
Hongkui Deng

Collection:

Editor’s selections: top articles from the past 3 years
Article Open Access 04 May 2022
Defined tumor antigen-specific T cells potentiate personalized TCR-T cell therapy and prediction of immunotherapy response

Jingjing He
Xinxin Xiong
Penghui Zhou

Collection:

Editor’s selections: top articles from the past 3 years
Article 14 Feb 2022
Meningeal lymphatics regulate radiotherapy efficacy through modulating anti-tumor immunity

Changping Zhou
Lu Ma
Jincai Luo
Article Open Access 17 Mar 2022
Gut microbiota drives macrophage-dependent self-renewal of intestinal stem cells via niche enteric serotonergic neurons

Pingping Zhu
Tiankun Lu
Zusen Fan
Article 04 Apr 2022
Discovery of small-molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and their preclinical neuroprotective activity

Hong Yao
Minghui Liu
Gelin Wang
Article 22 Apr 2022

Top of page ⤴

Letter to the Editor

Generic amyloid fibrillation of TMEM106B in patient with Parkinson’s disease dementia and normal elders

Yun Fan
Qinyue Zhao
Dan Li
Letter to the Editor Open Access 27 Apr 2022
Enhanced trimeric ACE2 exhibits potent prophylactic and therapeutic efficacy against the SARS-CoV-2 Delta and Omicron variants in vivo

Mengjiao Li
Zi-Wei Ye
Bobo Dang
Letter to the Editor Open Access 13 Apr 2022
Structural insights into the SARS-CoV-2 Omicron RBD-ACE2 interaction

Jun Lan
Xinheng He
Xinquan Wang
Letter to the Editor Open Access 13 Apr 2022
Synthetic lethal screening identifies DHODH as a target for MEN1-mutated tumor cells

Yarui Ma
Qing Zhu
Yuchen Jiao
Letter to the Editor 15 Feb 2022

Top of page ⤴

Correction

Author Correction: Receptome profiling identifies KREMEN1 and ASGR1 as alternative functional receptors of SARS-CoV-2

Yunqing Gu
Jun Cao
Zhigang Lu
Correction 01 Apr 2022

Top of page ⤴

Volume 32 Issue 6, June 2022

Research Highlight

Amplifying natural antitumor immunity for personalized immunotherapy

PEN2: Metformin’s new partner at lysosome

Krebs and an alternative TCA cycle!

Nuclear tetraspanin 8 promotes breast cancer progression

Article

Derivation of totipotent-like stem cells with blastocyst-like structure forming potential

Defined tumor antigen-specific T cells potentiate personalized TCR-T cell therapy and prediction of immunotherapy response

Meningeal lymphatics regulate radiotherapy efficacy through modulating anti-tumor immunity

Gut microbiota drives macrophage-dependent self-renewal of intestinal stem cells via niche enteric serotonergic neurons

Discovery of small-molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and their preclinical neuroprotective activity

Letter to the Editor

Generic amyloid fibrillation of TMEM106B in patient with Parkinson’s disease dementia and normal elders

Enhanced trimeric ACE2 exhibits potent prophylactic and therapeutic efficacy against the SARS-CoV-2 Delta and Omicron variants in vivo

Structural insights into the SARS-CoV-2 Omicron RBD-ACE2 interaction

Synthetic lethal screening identifies DHODH as a target for MEN1-mutated tumor cells

Correction

Author Correction: Receptome profiling identifies KREMEN1 and ASGR1 as alternative functional receptors of SARS-CoV-2

Search

Quick links